Conference abstract · 25 Nov 2019
Conference abstractPublished 9 May 2016
Analysis of pre-analytic factors affecting the success of next-generation sequencing of solid tumors
University of Texas MD Anderson Cancer Center, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Clinical laboratories are rapidly implementing next-generation sequencing (NGS) tests for mutation analysis, however there are few guidelines regarding sample quality for successful results. We aimed to establish tissue quality parameters for successful NGS in solid tumors and to improve NGS performance. Using a 50-gene hotspot mutation panel we identified the major cause for unsuccessful NGS analysis being DNA <10 ng, which was associated with extremely small and low cellularity samples. High success rates were associated with resection procedures and biopsied tumor >10 mm2. Independent factors leading to lower NGS success were cellular tumor areas and decalcification procedures. Tumor type and paraffin block age did not affect success. We optimized workflow and showed improved NGS success rates with pronounced improvement among tiny samples and cytology samples. Identifying pre-analytical tissue factors allows us to improve NGS performance and to successfully test tumors obtained from minimally invasive procedures.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Aug 2016
Size matters: Challenges in implementing large Next-generation sequencing panels for routine clinical screening of tumors
Conference abstract · 17 Oct 2016
Identification of tumor cellular origins by anchored multiplex PCR and next-generation sequencing
Commentary · 29 Oct 2021
Early Use of Next Generation Sequencing Provided Alternative Treatment Options to 32.24% of Advanced Stage Cancer Patients (Avoiding or Delaying Chemotherapy)-Retrospective Study in Solid Tumors at Beverly Hills Cancer Center
Case series · 2021
Early use of Next Generation Sequencing Provided Alternative Treatment Options to 32.24% Cancer Patients (Avoiding or Delaying Chemotherapy): Retrospective Study in Solid Tumors at Beverly Hills Cancer Center
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Hui Chen”
